, Tracking Stock Market Picks
Enter Symbol:
Rating: STJ

St. Jude Medical, Inc. (NYSE: STJ) downgraded to Hold by Stifel

Thursday,  Oct 22, 2015  8:25 AM ET by Kristen Bailey

Stifel downgraded St. Jude Medical, Inc. (NYSE: STJ) to Hold.
Stifel rated St. Jude Medical, Inc. (NYSE: STJ) to Buy with price target $66 on 10/16/2014, when the price was $55.61.

St. Jude Medical, Inc. (St. Jude)develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiology and cardiac surgery and atrial fibrillation therapy areas and implantable neurostimulation devices for the management of chronic pain. The Company operates in four business segments: Cardiac Rhythm Management (CRM), Cardiovascular (CV), Atrial Fibrillation (AF) and Neuromodulation Systems (Neuro). On July 3, 2008, the Company completed the acquisition of EP MedSystems, Inc. On December 19, 2008, St. Jude acquired Radi Medical Systems. On December 22, 2008, St. Jude acquired MediGuide Inc.


RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy